Clinical Trial Update: Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating Drugs [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating three doses of a Hepatitis A vaccine in patients on immunomodulating drugs; the current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Hepatitis A vaccine (inactivated Hepatitis A vaccine)

Snippet

Sponsor: Sormland County Council, Sweden | Conditions: Vaccine Response Impaired | Phase 2 | Status: UNKNOWN